The revenue declined to Rs. 105.81 millions for the quarter ended June 2023 as compared to Rs. 106.41 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -53.32 millions as compared to Net Loss of Rs. -81.36 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 improved to -25.82% as compared to -61.39% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 105.81 106.41 -0.56 105.81 106.41 -0.56 521.34 597.03 -12.68
Other Income 0.38 1.29 -70.54 0.38 1.29 -70.54 6.20 11.56 -46.37
PBIDT -25.82 -61.39 -57.94 -25.82 -61.39 -57.94 -151.59 -328.39 -53.84
Interest 10.97 3.04 260.86 10.97 3.04 260.86 29.73 53.91 -44.85
PBDT -36.79 -64.43 -42.90 -36.79 -64.43 -42.90 -181.32 -382.30 -52.57
Depreciation 16.53 16.93 -2.36 16.53 16.93 -2.36 65.59 62.97 4.16
PBT -53.32 -81.36 -34.46 -53.32 -81.36 -34.46 -246.91 -445.27 -44.55
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -53.32 -81.36 -34.46 -53.32 -81.36 -34.46 -246.91 -445.27 -44.55
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -24.40 -57.69 -57.70 -24.40 -57.69 -57.70 -29.08 -55.00 -47.14

Krebs Biochem.&Inds Share Price

83.40 3.40 (4.25%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.